Literature DB >> 8912630

Fas-mediated stimulation induces IL-8 secretion by rheumatoid arthritis synoviocytes independently of CPP32-mediated apoptosis.

C Sekine1, H Yagita, T Kobata, T Hasunuma, K Nishioka, K Okumura.   

Abstract

In this study, we investigated the IL-1 beta converting enzyme (ICE) family cysteine proteases responsible for the Fas-mediated apoptosis of rheumatoid arthritis (RA) synoviocytes and their involvement in proinflammatory cytokine production. CPP32 inhibitor, but not ICE inhibitor, was capable of inhibiting the Fas-mediated apoptosis of RA synovial cells. CPP32, but not ICE, was activated in response to anti-Fas stimulation. IL-8, but not IL-1 beta, was secreted from the anti-Fas-stimulated RA synoviocytes even in the presence of CPP32 inhibitor. These results demonstrated that CPP32, but not ICE, is the predominant cysteine protease that mediates the Fas-mediated apoptosis of RA synovial cells. We also demonstrated that anti-Fas stimulation of RA synoviocytes leads to IL-8 secretion independently of the CPP32-mediated apoptosis, which would accelerate inflammation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8912630     DOI: 10.1006/bbrc.1996.1610

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor.

Authors:  M Kawasaki; K Kuwano; N Hagimoto; T Matsuba; R Kunitake; T Tanaka; T Maeyama; N Hara
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Fas pulls the trigger on psoriasis.

Authors:  Amos Gilhar; Ron Yaniv; Bedia Assy; Sima Serafimovich; Yehuda Ullmann; Richard S Kalish
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

3.  Relationship of acute lung inflammatory injury to Fas/FasL system.

Authors:  Thomas A Neff; Ren-Feng Guo; Simona B Neff; J Vidya Sarma; Cecilia L Speyer; Hongwei Gao; Kurt D Bernacki; Markus Huber-Lang; Stephanie McGuire; L Marco Hoesel; Niels C Riedemann; Beatrice Beck-Schimmer; Firas S Zetoune; Peter A Ward
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

4.  Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically.

Authors:  Abdiaziz S Mohamood; Mehmet L Guler; Zuoxiang Xiao; Dongfeng Zheng; Allan Hess; Yi Wang; Hideo Yagita; Jonathan P Schneck; Abdel Rahim A Hamad
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

5.  Intracerebroventricular injection of anti-Fas activates the hypothalamus-pituitary-adrenal axis and induces peripheral interleukin-6 and serum amyloid A in mice: comparison with other ligands of the tumor necrosis factor/nerve growth factor receptor superfamily.

Authors:  F Benigni; S Sacco; L Aloe; P Ghezzi
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

6.  Fas activates lipolysis in a Ca2+-CaMKII-dependent manner in 3T3-L1 adipocytes.

Authors:  Reto A Rapold; Stephan Wueest; Adrian Knoepfel; Eugen J Schoenle; Daniel Konrad
Journal:  J Lipid Res       Date:  2012-10-21       Impact factor: 5.922

Review 7.  Can expression of CD95 (Fas/APO-1) ligand on grafts or tumor cells prevent their rejection?

Authors:  J Allison; K Seino; H Yagita
Journal:  Springer Semin Immunopathol       Date:  1998
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.